P

Inventor

WYMAN PAUL ADRIAN

GB28 patents
⚠️ This page may combine multiple inventors who share the name “WYMAN PAUL ADRIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SMITHKLINE BEECHAM PLC

24 patents
US5990133ANov 23, 1999

Indole derivatives as 5-HT receptor antagonist

SMITHKLINE BEECHAM PLC89 citations95
US6423717B1Jul 23, 2002

Sulphonamide derivatives, process for their preparation, and their use as medicaments

SMITHKLINE BEECHAM PLC33 citations92
US5972937AOct 26, 1999

Heterocyclic compounds possessing 5HT2C receptor antagonist activity

SMITHKLINE BEECHAM PLC28 citations92
US5852014ADec 22, 1998

Condensed indole derivatives as 5HT4 -receptor antagonists

SMITHKLINE BEECHAM PLC26 citations92
US5801170ASep 1, 1998

Heterocyclic biphenylylamides useful as 5HT1D antagonists

SMITHKLINE BEECHAM PLC21 citations92
US5705498AJan 6, 1998

Piperidine derivatives as 5-HT4 receptor antagonists

SMITHKLINE BEECHAM PLC30 citations92
US5726187AMar 10, 1998

N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists

SMITHKLINE BEECHAM PLC40 citations91
US5696129ADec 9, 1997

5-HT4 antagonists

SMITHKLINE BEECHAM PLC37 citations91
US5998409ADec 7, 1999

Condensed indole derivatives as 5HT4 -receptor antagonists

SMITHKLINE BEECHAM PLC18 citations84
US5889022AMar 30, 1999

Indole, indoline and quinoline derivatives with 5HT1D (anti-depressive) activity

SMITHKLINE BEECHAM PLC18 citations84
US6599904B2Jul 29, 2003

Sulphonamide derivatives, process for their preparation, and their use as medicaments

SMITHKLINE BEECHAM PLC14 citations83
US6159979ADec 12, 2000

Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity

SMITHKLINE BEECHAM PLC12 citations74
US5705509AJan 6, 1998

Tricyclic heterocyclic compounds as 5-HT4 receptor antagonists

SMITHKLINE BEECHAM PLC9 citations74
US6638953B2Oct 28, 2003

Indole derivatives as 5-HT receptor antagonist

SMITHKLINE BEECHAM PLC9 citations73
US5696122ADec 9, 1997

Indole and indoline derivatives as 5HT1D receptor antagonists

SMITHKLINE BEECHAM PLC16 citations72
US6391891B1May 21, 2002

Bicyclic compounds as ligands for 5-HT1 receptors

SMITHKLINE BEECHAM PLC10 citations71
US6066644AMay 23, 2000

Azaspiro derivatives with 5HT1B activity

SMITHKLINE BEECHAM PLC3 citations63
US6939891B2Sep 6, 2005

Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists

SMITHKLINE BEECHAM PLC3 citations62
US6235758B1May 22, 2001

Indole derivatives as 5-HT receptor antagonist

SMITHKLINE BEECHAM PLC2 citations62
US6100272AAug 8, 2000

Tetracyclic spiro compounds as 5HT1B receptor antagonists

SMITHKLINE BEECHAM PLC2 citations62
US5972951AOct 26, 1999

Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists

SMITHKLINE BEECHAM PLC6 citations62
US5952325ASep 14, 1999

Tricyclic spiro compounds process for their preparation and their use of 5HT1D receptor antagonists

SMITHKLINE BEECHAM PLC3 citations62
US6747030B1Jun 8, 2004

Piperazine derivatives as 5-HT1B antagonists

SMITHKLINE BEECHAM PLC2 citations61
US7109201B2Sep 19, 2006

Piperazine derivatives, their preparation and uses in therapy

SMITHKLINE BEECHAM PLC1 citations52

COOPER DAVID GWYN

3 patents

GLAXO GROUP LTD

1 patent